Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$0.34 - $0.48 $3,400 - $4,800
10,000 New
10,000 $4,000
Q1 2022

May 16, 2022

BUY
$0.92 - $1.94 $4,600 - $9,700
5,000 Added 100.0%
10,000 $13,000
Q3 2020

Nov 16, 2020

BUY
$1.75 - $8.19 $8,750 - $40,950
5,000 New
5,000 $9,000

Others Institutions Holding VCNX

About VACCINEX, INC.


  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $154M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Vectors Research Management, LLC Portfolio

Follow Vectors Research Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.